The Danish pharmaceutical company said it would cut 9,000 jobs, 5,000 of them in Denmark, in order to strengthen the ...

Novo Nordisk, the maker of weight loss drug Wegovy, will lay off about 9,000 people as it grapples with rising competition in ...

The maker of the popular weight-loss drug Wegovy announced on Wednesday that it will be cutting 9,000 jobs in the company.

Drugmaker Novo Nordisk will slash thousands of jobs in a sweeping effort to keep the company competitive in the ...

Ozempic and Wegovy maker Novo Nordisk says it will layoff about 9,000 employees of its global workforce as it restructures in an attempt to fend off competition.

Novo Nordisk cited a "more competitive and consumer-driven" market while announcing the elimination of 9,000 roles.

The Danish pharma giant outlined proposals to shed around 11% of its 78,400-strong workforce amid stiff competition from ...

Novo Nordisk, the Danish pharmaceutical giant known for manufacturing Ozempic and Wegovy, has announced plans to slash about ...

This article reviews the safety, efficacy, and regulatory concerns related to compounded semaglutide, with a focus on how health care providers can offer guidance and education to patients.